EZH2 inhibition using a selective chemical inhibitor GSK503, which targets the enzymatic activity of EZH2, significantly reduced the accumulation of H3K27me3 at tumor suppressor gene promoter regions, which lead to a significant decrease in tumor cells proliferation [89]. The gene discussed is EZH2; the disease is neoplasm.